The Cooper Companies, Inc. $COO Shares Sold by Bank of America Corp DE

Bank of America Corp DE lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.5% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,438,113 shares of the medical device company’s stock after selling 22,431 shares during the period. Bank of America Corp DE’s holdings in Cooper Companies were worth $102,825,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of COO. Wellington Management Group LLP lifted its holdings in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares during the last quarter. Generation Investment Management LLP bought a new position in shares of Cooper Companies during the fourth quarter valued at approximately $233,539,000. Diamond Hill Capital Management Inc. grew its holdings in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after purchasing an additional 2,720,594 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the period. Finally, Franklin Resources Inc. boosted its position in Cooper Companies by 108.2% during the 4th quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after purchasing an additional 2,089,763 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Citigroup restated a “neutral” rating and set a $76.00 price objective (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. Robert W. Baird reduced their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. BNP Paribas Exane dropped their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday, June 8th. Finally, Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of “Hold” and an average price target of $81.36.

Cooper Companies Stock Up 1.2%

Shares of Cooper Companies stock opened at $74.23 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The business’s fifty day moving average price is $69.64 and its two-hundred day moving average price is $71.51. The company has a market capitalization of $14.48 billion, a P/E ratio of 62.91, a PEG ratio of 1.92 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.